Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Penehyclidine hydrochloride for prevention of postoperative nausea and vomiting after laparoscopic bariatric surgery
ChiCTR2100052418Phase 4Not yet recruiting
- Sponsor
- Department of Anesthesiology and Perioperative Medicine, The First Affiliated Hospital of Nanjing Medical University
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of penehyclidine in postoperative nausea and vomiting (PONV) (2 arms), sponsored by Department of Anesthesiology and Perioperative Medicine, The First Affiliated Hospital of Nanjing Medical University. Primary endpoint: Incidence of postoperative nausea and vomiting. Planned start Jun 2020; status: not yet recruiting.
02
Drugs
penehyclidine
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on ChiCTR2100052418.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100052418.